Wiley Matthew T. 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Wiley Matthew T.（CIK 1759703）在 1 家公司共报告 6 笔 SEC Form 4 内部人交易（最近一笔 2026-09-29）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-29 | Definium Therapeutics, Inc. (DFTX) | Chief Commercial Officer | 卖出 | 3,097 | $113,257 |
| 2026-09-14 | Definium Therapeutics, Inc. (DFTX) | Chief Commercial Officer | 买入 | 125,000 | $0 |
| 2026-08-12 | Definium Therapeutics, Inc. (DFTX) | Chief Commercial Officer | 买入 | 62,500 | $0 |
| 2026-06-26 | Definium Therapeutics, Inc. (DFTX) | Chief Commercial Officer | 卖出 | 2,867 | $129,101 |
| 2026-06-22 | Definium Therapeutics, Inc. (DFTX) | Chief Commercial Officer | 买入 | 62,500 | $0 |
| 2026-02-05 | Definium Therapeutics, Inc. (DFTX) | Chief Commercial Officer | 买入 | 115,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-29